Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site) FDA Record
- Latest inspection VAI · Apr 15, 2026
- No warning letters matched by name
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site) has 0 FDA recalls, 6 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site)" is on file.
- Latest inspection
- Apr 15, 2026 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 6 | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site): FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site) as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site) yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Apr 15, 2026 | Lianyungang, China | Drugs | Voluntary Action Indicated (VAI) | 3006689263 |
| Apr 13, 2018 | Lianyungang, China | Drugs | Voluntary Action Indicated (VAI) | 3006689263 |
| Aug 28, 2015 | Lianyungang, China | Drugs | No Action Indicated (NAI) | 3006689263 |
| Sep 10, 2013 | Lianyungang, China | Drugs | No Action Indicated (NAI) | 3006689263 |
| Aug 20, 2013 | Lianyungang, China | Drugs | No Action Indicated (NAI) | 3006689263 |
| Aug 1, 2012 | Lianyungang, China | Drugs | No Action Indicated (NAI) | 3006689263 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3006689263 | Lianyungang, China | 6 | Apr 15, 2026 |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site) and the FDA: common questions
Has Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site) received an FDA warning letter?
No FDA warning letter addressed to the name "Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site)" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site) received an FDA Form 483?
FDA has not published a Form 483 for "Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site)" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site)?
The most recent FDA inspection on file ended Apr 15, 2026 at Lianyungang, China and was classified VAI. FDA has 6 inspections of Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site) on file.
Need more than this page shows? Ask about Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site) in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.